Explaining risks and benefits of loco-regional treatments to patients by Ana-Alicia Beltran-Bless, Stephanie Kacerovsky-Strobl, Michael Gnant

Get full text

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management by Giuseppe Curigliano, Fatima Cardoso, Michael Gnant, Nadia Harbeck, Judy King, Anne-Vibeke Laenkholm, Frédérique Penault-Llorca, Aleix Prat

Get full text

Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Ca... by Elisabeth S. Gruber, Georg Oberhuber, Peter Birner, Michaela Schlederer, Michael Kenn, Wolfgang Schreiner, Gerd Jomrich, Sebastian F. Schoppmann, Michael Gnant, William Tse, Lukas Kenner

Get full text

The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer by Elisabeth S. Gruber, Georg Oberhuber, Peter Birner, Michaela Schlederer, Michael Kenn, Wolfgang Schreiner, Gerd Jomrich, Sebastian F. Schoppmann, Michael Gnant, William Tse, Lukas Kenner

Get full text

Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patien... by Michael Gnant, Khatijah Lim Abdullah, Frances Boyle, Chiun-Sheng Huang, Katie Bickford, Sola Neunie, Alexander Noble, Anne Nunn, Caroline Sproat, Nadia Harbeck, Carlos Barrios

Get full text

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialResearch in context by Alexios Matikas, Andri Papakonstantinou, Sibylle Loibl, Günther G. Steger, Michael Untch, Hemming Johansson, Nikos Tsiknakis, Mats Hellström, Richard Greil, Volker Möbus, Michael Gnant, Jonas Bergh, Theodoros Foukakis

Get full text

Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis by Gudrun Piringer, Gudrun Piringer, Gudrun Piringer, Florian Ponholzer, Josef Thaler, Josef Thaler, Thomas Bachleitner-Hofmann, Holger Rumpold, Holger Rumpold, Alexander de Vries, Lukas Weiss, Lukas Weiss, Richard Greil, Richard Greil, Michael Gnant, Dietmar Öfner

Get full text

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients by Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler, Florian Fitzal

Get full text

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study by Gudrun Piringer, Gudrun Piringer, Thomas Gruenberger, Josef Thaler, Josef Thaler, Irene Kührer, Klaus Kaczirek, Friedrich Längle, Istvan Viragos-Toth, Arno Amann, Wolfgang Eisterer, Reinhold Függer, Johannes Andel, Angelika Pichler, Judith Stift, Lidija Sölkner, Michael Gnant, Dietmar Öfner

Get full text

Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine by Viktoria Knöbl, Lukas Maier, Stefan Grasl, Carmen Kratzer, Felix Winkler, Vanessa Eder, Hubert Hayden, Maria Amparo Sahagun Cortez, Monika Sachet, Rudolf Oehler, Sophie Frantal, Christian Fesl, Karin Zehetner, Georg Pfeiler, Rupert Bartsch, Florian Fitzal, Christian F. Singer, Martin Filipits, Michael Gnant, Christine Brostjan

Get full text

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study by Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker, Ana-Alicia Beltran-Bless, Gregory Pond, Lisa Vandermeer, Dhenuka Radhakrishnan, Lucy Mosquera, Alexander Paterson, Lois Shepherd, Bingshu Chen, William Barlow, Julie Gralow, Marie-France Savard, Christian Fesl, Dominik Hlauschek, Marija Balic, Gabriel Rinnerthaler, Richard Greil, Michael Gnant, Mark Clemons, Khaled El Emam

Get full text

Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109) by Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators

Get full text